KPD PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KPD PHARMA
Largest movements
- Intangible fixed assets -€17,300
down €17,300 (-50.1%), from €34,557 to €17,257
- Cash -€1,302
down €1,302 (-2.9%), from €44,708 to €43,407
mainly Net result for the year (-€18,602)
- Equity -€18,602
down €18,602, from €15,812 to -€2,790
of which Reserves: -€15,570
- Gross operating margin -€1,307
down €1,307, from €36 to -€1,272
- Financial charges +€30
new in 2021: €30
From the 2020 result to the 2021 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2020 and 2021 balance sheets and the 2021 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2020 | 2021 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €79,617 | €61,015 | -€18,602 | -23.4% |
| Fixed assets | 21/28 | €34,557 | €17,257 | -€17,300 | -50.1% |
| Intangible fixed assets | 21 | €34,557 | €17,257 | -€17,300 | -50.1% |
| Current assets | 29/58 | €45,059 | €43,758 | -€1,302 | -2.9% |
| Amounts receivable within one year | 40/41 | €351 | €351 | = | 0.0% |
| Other amounts receivable | 41 | - | €351 | +€351 | |
| Cash at bank and in hand | 54/58 | €44,708 | €43,407 | -€1,302 | -2.9% |
| Total equity and liabilities | 10/49 | €79,617 | €61,015 | -€18,602 | -23.4% |
| Equity | 10/15 | €15,812 | -€2,790 | -€18,602 | |
| Contributions | 10/11 | - | €51,848 | +€51,848 | |
| Reserves | 13 | €456,196 | €440,626 | -€15,570 | -3.4% |
| Non-distributable reserves | 130/1 | - | €3,831 | +€3,831 | |
| Reserves not available under the articles | 1311 | - | €3,831 | +€3,831 | |
| Tax-exempt reserves | 132 | - | €296,496 | +€296,496 | |
| Distributable reserves | 133 | - | €140,299 | +€140,299 | |
| Profit (loss) carried forward | 14 | -€492,233 | -€495,265 | -€3,032 | -0.6% |
| Amounts payable | 17/49 | €63,805 | €63,805 | = | 0.0% |
| Amounts payable within one year | 42/48 | €63,805 | €63,805 | = | 0.0% |
| Taxes, remuneration and social security | 45 | - | €105 | +€105 | |
| Taxes | 450/3 | - | €105 | +€105 | |
| Other amounts payable | 47/48 | - | €63,700 | +€63,700 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,300 | €17,300 | = | 0.0% |
| Gross operating margin | 9900 | €36 | -€1,272 | -€1,307 | |
| Operating profit (loss) | 9901 | -€17,827 | -€18,572 | -€745 | -4.2% |
| Financial charges | 65/66B | - | €30 | +€30 | |
| Recurring financial charges | 65 | €20 | €30 | +€10 | +50.0% |
| Profit (loss) for the period before taxes | 9903 | -€17,847 | -€18,602 | -€755 | -4.2% |
| Profit (loss) for the period | 9904 | -€17,847 | -€18,602 | -€755 | -4.2% |
| Transfer from tax-exempt reserves | 789 | - | €15,570 | +€15,570 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,277 | -€3,032 | -€755 | -33.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2020 and 31 December 2021. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.